MARKEN DELIVERS CLINICAL DRUGS DURING COVID-19

Tags:
ESSENTIAL SERVICES CROSSING SERBIA’S CLOSED BORDERS

 

GOAL

To deliver urgently required temperature-controlled clinical medication to several hospitals in Serbia.

 

CHALLENGE

With all commercial international traffic halted, our planning review resulted in limited options that avoided delays:

  • The only remaining cargo flight was fully booked.
  • Air cargo road transport would be a 4-day transit in an uncontrolled temperature truck.
  • Driving into Serbia would require a 14-day quarantine of the driver.
  • Necessary import staff from Serbia’s Ministry of Traffic were not initially reachable due to countrywide stay-at-home work restrictions.

 

SOLUTION

In order to import these time-critical and temperature sensitive drugs, Marken chartered a Cessna from Zurich to Belgrade. The night prior to takeoff, we had not yet received landing permission. We informed the client but given the urgency of this shipment, we were asked to continue all efforts to try and Make it Happen.

Through collaborative efforts of Marken’s team members, we received the necessary permit from Serbia’s Ministry of Traffic just 3 hours before takeoff at Zurich. We successfully delivered multiple shipments to several hospitals throughout Belgrade.

 

OUTCOME

Hospitals and patients received their critical drug supply within the necessary time and temperature requirements.

 

About Marken

 Marken is a wholly owned subsidiary of the UPS Healthcare Division. With Polar Speed and Marken included, the UPS division staffs 128 locations with 5000 employees worldwide. Marken maintains the leading position for Direct to Patient and Home Health care services, biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistics hubs in 54 locations worldwide for clinical trial material storage and distribution. Marken’s dedicated 1200 staff members manage 90,000 drug and biological shipment every month at all temperature ranges in more than 220 countries Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy as to Marken’ unique position in the pharma and logistics industry.

Issued March 2020

Back to Index